Title: RIP140 Regulation of Glucose Transport
Patent Number: 7,691,823
Filed: March 7, 2005
Lead Inventor: Michael Czech, University of Massachusetts (RXi Pharmaceuticals)
"Inhibition of RIP140 increases glucose transport," the patent's abstract states. "Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport, treating obesity, increasing metabolism, and increasing brown fat."